Our Science

Creating a New Paradigm
for Shelf-Stable, Allogeneic Cellular Therapies

Cellphire Therapeutics has developed a first-in-class technology to stabilize and store human cells for years.  Our technology platform enables development of novel cellular therapies to address a range of unmet medical needs.  Our ability to blend cells from multiple donors and to reduce pathogens allows us to provide a consistent, safe product at commercial scale.

Cellphire has two investigational products in Phase 2 clinical trials, including Thrombosomes®, a stabilized platelet-derived biologic, and Cryopreserved Platelets (CPP).

Want to hear more about our trials and research?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.